Meanwhile, Nanegrungsunk et al. [35] explore technological and pharmacological innovations that aim to reduce the treatment burden for AMD, such as long-acting anti-VEGF agents and gene therapy. The gene discussed is VEGFA; the disease is age-related macular degeneration.